Research with older people in a world with COVID-19: identification of current and future priorities, challenges and opportunities

Abstract Older people are disproportionately affected by the COVID-19 pandemic, which has had a profound impact on research as well as clinical service delivery. This commentary identifies key challenges and opportunities in continuing to conduct research with and for older people, both during and after the current pandemic. It shares opinions from responders to an international survey, a range of academic authors and opinions from specialist societies. Priorities in COVID-19 research include its specific presentation in older people, consequences for physical, cognitive and psychological health, treatments and vaccines, rehabilitation, supporting care homes more effectively, the impact of social distancing, lockdown policies and system reconfiguration to provide best health and social care for older people. COVID-19 research needs to be inclusive, particularly involving older people living with frailty, cognitive impairment or multimorbidity, and those living in care homes. Non-COVID-19 related research for older people remains of critical importance and must not be neglected in the rush to study the pandemic. Profound changes are required in the way that we design and deliver research for older people in a world where movement and face-to-face contact are restricted, but we also highlight new opportunities such as the ability to collaborate more widely and to design and deliver research efficiently at scale and speed.

[1]  Antonio Cherubini,et al.  The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. , 2011, Archives of internal medicine.

[2]  Janice L. Krieger,et al.  Audience segmentation as a strategy for enhancing the use of research registries for recruiting patients into clinical trials , 2019, Contemporary clinical trials communications.

[3]  I. J. Douglas,et al.  OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. , 2020, medRxiv.

[4]  J. Hewitt,et al.  A multi-centre, UK-based, non-inferiority randomised controlled trial of 4 follow-up assessment methods in stroke survivors , 2019, BMC Medicine.

[5]  Matthias Briel,et al.  Current use and costs of electronic health records for clinical trial research: a descriptive study. , 2019, CMAJ open.

[6]  L. Corner,et al.  Priorities for research in multiple conditions in later life (multi-morbidity): findings from a James Lind Alliance Priority Setting Partnership. , 2019, Age and ageing.

[7]  G. Onder,et al.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. , 2020, JAMA.

[8]  T. Hoffmann,et al.  Waste in covid-19 research , 2020, BMJ.

[9]  Gail,et al.  International Severe Acute Respiratory and emerging Infections Consortium Partners^ , 2016 .

[10]  J. Higgins,et al.  COVID-19 in Older People: A Rapid Clinical Review , 2020, Age and ageing.

[11]  S. Tagliaferri,et al.  Assessment and treatment of older individuals with COVID-19 multi-system disease: clinical and ethical implications , 2020, Acta bio-medica : Atenei Parmensis.